How to better manage drug plans
Some stakeholders in the health benefits community believe that the cost of new (patented) medicines threatens the sustainability of prescription drug benefits in Canada. At the same time, cost concerns are encouraging drug plan sponsors to shift to plan designs that limit access to the most innovative treatments.
- March 31, 2014 September 13, 2019
- 07:00